In human HCC specimens, nuclear translocation of SKP2, was associated with activation of the AKT/mTOR and RAS/RAF/MAPK pathways to promote hepatocarcinogenesis in vivo (Delogu et al., 2015). This evidence concerns the gene MTOR and hepatocellular carcinoma.